SLFN11 Loss-Induced Chemoresistance is Associated with Overexpression of Glycerophospholipid Biosynthesis in Ewing Sarcoma.
Chakraborty, K.; Burman, R.; Satheesh, S.; Kieffer, M.; Karuhatty, C.; Yuan, Z.-F.; Tan, H.; Lkhagva, A.; High, A. A.; Wang, X.; Refaat, A.; Zhang, W.; Wang, Y.; Fan, Y.; Babu, M. M.; Shelat, A.; Stewart, E.; Dyer, M. A.; Bagga, P.
Show abstract
Ewing sarcoma (EWS) is an aggressive cancer in adolescents and young adults with frequent relapse rates and poor outcomes in recurrent or metastatic cases. Schlafen family member 11 (SLFN11) gene is associated with the sensitivity to DNA-damaging agents (DDAs). The knockout of SLFN11 is associated with acquired chemoresistance in both cell lines and preclinical models. Here, we aimed to elucidate the metabolic underpinnings of SLFN11-loss associated chemoresistance in patient derived cell lines of EWS. Our integrated transcriptomic and metabolomic analyses revealed downregulation of mitochondrial glycerol-3-phosphate dehydrogenase 2 (GPD2) gene, which was accompanied by the upregulation of glycerophospholipid (GPL) biosynthesis pathway. Further, therapeutic targeting of lipid synthesis with the glycerol-3-phosphate acyltransferase 1 (GPAT1) inhibitor (FSG67) enhanced the efficacy of the DDA (SN-38) in SLFN11-/- cells. These findings indicate that SLFN11 loss-mediated chemoresistance can be targeted by blocking GPL biosynthesis in addition to DDA administration.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Metabolic regulation of RNA methylation by the m6A-reader IGF2BP3 94%
- MAPK14/p38α Shapes the Molecular Landscape of Endometrial Cancer and promotes Tumorigenic Characteristics 94%
- Androgen receptor inhibition induces metabolic reprogramming and increased reliance on oxidative mitochondrial metabolism in prostate cancer 94%
Similar papers in this journal
Similar papers in this journal
- EZH2 inhibition promotes tumor immunogenicity in lung squamous cell carcinomas 93%
- WNT4 regulates cellular metabolism via intracellular activity at the mitochondria in breast and gynecologic cancers 92%
- Targeting the glucose-insulin link in head and neck squamous cell carcinoma induces cytotoxic oxidative stress and inhibits cancer growth 92%
Similar papers in this journal
- DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptation 94%
- The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage. 94%
- Folate depletion induces erythroid differentiation through perturbation of de novo purine synthesis 93%
Similar papers in this journal
- Nutrient availability dictates cancer metabolism-based therapeutic responses of non-oncology drugs 95%
- PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma 94%
- Pharmacologically targeting KRASG12D in PDAC models:tumor cell intrinsic and extrinsic impact 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.